
|Articles|August 25, 2021
Data MATRIX Introduces AI-operated Patient Survival Assessment Tool
Advertisement
A feature of the presented tool for predictive analysis of Real-World Data (RWD) is the ability to collect and analyze data on different patient cohorts. Machine algorithms collect information about patients from medical records received from prevention and treatment facilities, pharmaceutical companies, and researchers in 29 regions of the Russian Federation.
As a result, pharmaceutical and biotech companies will have a legally compliant provider of RWD derived from millions of EHRs. This will aim to contribute to the overall knowledge base on drugs efficacy and safety, including those of vaccines.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5



